Physician profile
Carmen E Peden
NPI 1902994460
$17,127.14
in general payments reported to CMS, 2019-2025
48 companies · $746 in 2025
The $746 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,084 · 2021: $450 · 2022: $568 · 2023: $622 · 2024: $1,241 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,594 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,594.25 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11,268.92 | 2019-2023 | |
| Gyrus Acmi, INC. | $1,815.00 | 2020 | |
| Hologic Sales and Service, LLC | $409.02 | 2022-2025 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Amgen INC. | $406.07 | 2020-2025 | Evenity, Prolia |
| Meditrina | $351.11 | 2023-2025 | |
| Astellas Pharma US INC | $303.51 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $247.42 | 2021-2022 | |
| Sage Therapeutics, LLC | $205.02 | 2021-2025 | Zurzuvae |
| Duchesnay USA Incorporated | $150.92 | 2019 | |
| Caldera Medical, INC | $149.18 | 2019 | |
| Daiichi Sankyo INC. | $115.84 | 2020-2022 | |
| Ethicon US, LLC | $113.63 | 2022-2025 | Vistaseal, Stratafix, Ethicon |
| Pfizer INC. | $107.33 | 2022-2024 | |
| Organon LLC | $106.34 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.38 | 2020-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $86.90 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $86.48 | 2019-2025 | Paragard T 380a, Paragard T 380a, Mara Console |
| Merck Sharp & Dohme LLC | $78.19 | 2019-2025 | Gardasil 9 |
| Therapeuticsmd, INC. | $69.19 | 2020-2022 | |
| Evofem Biosciences, INC. | $67.87 | 2021-2022 | |
| Millicent US INC | $65.68 | 2024-2025 | Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $61.42 | 2021-2023 | Twirla |
| Baxter Healthcare | $59.45 | 2023 | Tisseel |
| Mayne Pharma Commercial LLC | $52.37 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $52.35 | 2020-2022 | |
| Dysis Medical, INC. | $44.71 | 2020 | |
| Monaghan Medical Corporation | $43.09 | 2023-2024 | Aerobika, Aerochamber |
| Northgate Technologies, INC. | $41.01 | 2023-2024 | Nti Branded Other (Nti), Smoke Removal -Nebulae Srs |
| Avion Pharmaceuticals | $37.99 | 2019-2021 | |
| Coloplast Corp | $37.68 | 2021-2025 | |
| Lupin INC. | $36.99 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $33.33 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Ascend Therapeutics US, LLC | $32.82 | 2022-2024 | |
| Medicem INC. | $30.05 | 2021 | |
| Covidien LP | $29.05 | 2019 | |
| Smith+Nephew, INC. | $27.02 | 2019-2021 | |
| Channel Medsystems, INC. | $23.21 | 2023 | |
| Radius Health, INC. | $20.48 | 2023 | Tymlos |
| Biohaven Pharmaceuticals, INC. | $19.70 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $18.60 | 2023 | Vivjoa |
| Aspira Women'S Health INC | $17.77 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.37 | 2019 | |
| Convatec INC. | $17.31 | 2022 | |
| Mimedx Group, INC. | $14.98 | 2024 | |
| Boston Scientific Corporation | $14.03 | 2023 | |
| Vyne Pharmaceuticals INC. | $12.84 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.39 | 2019 | |
| Allergan, INC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Peden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.